Rutherford Health Plc

AQSE Growth Market -
Rutherford Health plc (formerly Proton Partners International Limited) is the UK incorporated holding company of a group committed to providing innovative cancer care of the highest quality. The Group's three oncology centres in the UK, named The Rutherford Cancer Centres, offer a comprehensive range of cancer treatments to patients including proton beam therapy (“PBT”), conventional radiotherapy, chemotherapy, immunotherapy, imaging and wellbeing services.

The three centres, based in Newport, South Wales, Bomarsund, Northumberland and at Reading, are the first to offer high energy proton beam therapy in the United Kingdom with the first patients having received PBT at the Group's oncology centre in Newport in April 2018.

Symbol Ccy Code Bid Ask Mid Previous Close Volume Last Traded
RUTH GBX 200 208 204 204 1000 29.03.21

MiFID II compliant pre- and post-trade transaction data is available here. The data is delayed by at least 15 minutes and will be refreshed every 15 minutes. Publication of trades in equity securities that are large in scale compared to normal market size and illiquid non-equity securities may be delayed if the trade is eligible for deferred publication in accordance with the trading rules of Aquis Stock Exchange and MiFIR. Further details as to when the publication of a trade may be deferred are set out in the trading rules which are available here.

Key Information

  
Market Cap: £403.94m
ISIN:GB00BJCWB146
Par:0.001
Inst Type:Ordinaries
Symbol:RUTH
MIFID Status:MTF
Tradable securities in issue:198,011,700
Sector:Health Care Equipment & Services
Last results date:29.02.20
% price change since listing:-10.33%
% daily price change:0.00%

Latest Trades

Date & Time Volume Price
29.03.21  |  10:29:591000200
16.02.21  |  16:38:192370208
30.11.20  |  09:28:27267220
30.07.20  |  13:17:19500210
22.06.20  |  15:11:52408245
31.10.19  |  11:47:32412245
18.04.19  |  13:14:42155245

Latest Announcements

Date & Time Title
05.05.21  |  07:00:00Rutherford Health - Drawdown of £15m from Infrastructure Investment
23.03.21  |  07:00:00Rutherford Health - £40m infrastructure investment
01.03.21  |  07:00:00Rutherford Health - Appointment of Finance Director
03.02.21  |  07:00:00Rutherford Health - Start of radiotherapy services in Liverpool
18.01.21  |  07:00:00Rutherford Health - Trading and Funding Update
13.01.21  |  10:10:00Rutherford Health - Agreement to provide services to NHS
09.12.20  |  09:30:00Rutherford Health - Rutherford Health announces membership plan
30.11.20  |  07:00:00Rutherford Health - Half-year Report
28.08.20  |  08:30:00Rutherford Health - Total Voting Rights
25.08.20  |  10:23:00Rutherford Health - Holding(s) in Company

Financial Information

Click here to download a glossary of terms.

All data provided by Fregnan.

29.02.20
Enterprise Value £398.33m
EV/EBITDA (20.48)
EV/EBIT (15.64)
   
PE Ratio (16)
PEG (0.21)%
Dividend Yield -
Free Cash Yield (13.71)%

Click here to download a glossary of terms.

All data provided by Fregnan.

28.02.18
(£'000)
28.02.19
(£'000)
29.02.20
(£'000)
Income Statement      
Revenue 181,4655,606
Operating Income (EBIT) (10,554)(19,280)(25,468)
Net Income (8,679)(18,265)(24,434)
       
Balance Sheet      
Cash 6,69520,58919,157
Total Debt 13,14924,51510,586
Total Liabilities 24,96752,69026,530
Total Equity 94,014118,410167,513
       
Operating Margin (58,633.33)%(1,316.04)%(454.30)%
EPS - Basic (7.53)p(14.19)p(14.22)p
EPS - Growth -88.48%0.21%
Dividend Per Share ---
Average Shares Outstanding 115.31m128.76m171.89m
       
ROA -(12.59%)(13.38%)
ROCE -(15.42%)(15.87%)
ROE -(17.20%)(17.09%)

Click here to download a glossary of terms.

All data provided by Fregnan.

28.02.18
(£'000)
28.02.19
(£'000)
29.02.20
(£'000)
Revenue 181,4655,606
Cost of Revenue -2,8725,190
Depreciation & Amortisation 1,0033,6646,020
Gross Profit (985)(5,071)(5,604)
Other Operating Expenses 9,56914,20919,864
Operating Income (EBIT) (10,554)(19,280)(25,468)
Net Interest Expense 1,0342,3933,615
Unusual Expense (incl. Exceptionals) ---
Non-Operating Expense 77155(193)
Profit (pre-tax) (11,511)(21,518)(29,276)
Taxation 2,8323,2534,842
Other Expenses and Minortity Interest ---
Net Income (8,679)(18,265)(24,434)

Click here to download a glossary of terms.

All data provided by Fregnan.

28.02.18
(£'000)
28.02.19
(£'000)
29.02.20
(£'000)
Cash from Operations (4,957)1,408(34,046)
Cash from Investing (40,606)(42,057)(19,550)
Cash from Financing 17,11754,54352,164
Other Miscellaneous ---
Net Cash Flow (28,446)13,894(1,432)

Click here to download a glossary of terms.

All data provided by Fregnan.

28.02.18
(£'000)
28.02.19
(£'000)
29.02.20
(£'000)
Current Assets 13,93627,50429,380
Non-Current Assets 105,045143,596164,663
Total Assets 118,981171,100194,043
Current Liabilities 11,81828,17515,944
Non-Current Liabilities 13,14924,51510,586
Total Liabilities 24,96752,69026,530
Net Assets 94,014118,410167,513
Total Equity 94,014118,410167,513

Click here to download a glossary of terms.

All data provided by Fregnan.

Address

Business Address

Rutherford Health plc, Suite 4 Penn House, 9-10 Broad Street, Hereford, HR4 9AP, United Kingdom.

Registered Address

15 Bridge Street, Hereford, HR4 9DF, United Kingdom.

Contacts

Corporate Adviser

Grant Thornton UK LLP., 30 Finsbury Square, London, United Kingdom.

Email: website.enquiries.general@uk.gt.com

Phone: 020 7383 5100

Registrar

Share Registrars Ltd, The Courtyard, 17 West Street, Farnham, Surrey, GU9 7DR, United Kingdom.

Email: enquiries@shareregistrars.uk.com

Phone: 01252 821390

Research


I'm sorry there is no research for this company.